Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MedTech
MedTech
Beckman Coulter grows Alzheimer’s dx portfolio with CE mark
Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.
Joseph Keenan
Jul 7, 2026 10:55am
Novo Nordisk pens GLP-1 implant tech deal with Vivani Medical
Jul 7, 2026 9:07am
NICE recommends 2 new diagnostics for endometriosis
Jul 7, 2026 8:35am
Exact Imaging boosts U.S. commercial team
Jul 6, 2026 7:47am
Caris Life Sciences launches cancer blood test ‘Caris Detect’
Jul 6, 2026 7:40am
AstraZeneca pays CSPC $30M to form kidney drug discovery pact
Jul 3, 2026 8:00am
